Monteloeder SL   Report issue

For profit
Founded: Elche Spain (1996)
Status: No NME R&D (1996)

Organization Overview

First Clinical Trial
2015
NCT03568877
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Monteloeder SL

Active Ingredients

Drugs in Other Trials (2)

hibiscus sabdariffa (2 trials)

verbena (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2